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   In 14 patients from which methicillin-resistant Staphylococcus a reus (MRSA) was isolated at the 
Department of Urology, Tone Chuo Hospital between June, 1992 and October, 1993, the site of 
infection, background of patients, and drug resistance were analyzed. 
   The 14 patients consisted of 11 males and 3 females between 45 and 85 years old with a mean 
of 71.6 years. The site from which MRSA was isolated was urine in 11, wound in 2, nasal cavity 
in 1, pharynx in  1, and renal fistula in 1 (detected at 2 or more sites in 2). The underlying 
condition was prostate hyperplasia in 2, prostate cancer in 4 (after radical prostatectomy in 1, 
complicated by bladder stone in 1), bladder tumor in 3, (during bladder instillation of BCG in 
I), perirenal  abcess in 2, renal pelvic tumor in 1, neurogenic bladder in 1, and after Boari' s 
operation in 1. Urethral catheterization had been performed in 3. A fever of 38°C or above 
was noted in 3. Mixed infection was observed in 10, and was caused by Escherichia coli in 2, Pro-
teus mirabiris in 1, Candida in 1, Klebsiella in 2, Pseudomonas aeruginosa in 2, and Serratia in 2. Four 
patients has previously been administered antibiotics, which were third generation cephems in 3 and 
penicillin in 1. The drug sensitivity was 100% for vancomycin (VCM), 30% for imipenam (IMP), 
31% for minomycin (MINO), 31% for amikacin (AMK), and 7% for fosfomycin (FOM). As 
for chemotherapy,  VCM+FOM+sulbactam/cefoperazone were administered to 6, and ceftazidime+ 
MINO were admin-istered to 1. Concerning surgery, transurethral resection of prostate (TUR-P) 
was made in 2, transurethral resection of bladder tumor (TUR-Bt) in 1, washing of the wound with 
Isodine and dressing with formgauze in 2, and transurethral lithotripsy in 1. Five patients who 
showed no urinary symptoms were observed without treatments. MRSA disappeared in 12 but 
persisted in 2 untreated patients. 
   In conclusion, 1) few patients with urinary tract infection by  MRSA showed severe symptoms, 
but a patient with complete urinary tract obstruction had a severe clinical course; 2) mixed 
infection of MRSA and Gram-negative bacteria was observed in many patients; and 3) multiple 
chemotherapy including VCM was effective for elimination of the bacteria. 
                                               (Acta Urol. Jpn. 40: 997-1003,1994) 


















と して,年 齢,性 別,分 離部 位,基 礎 疾患,先 行 抗 生
物 質,薬 剤 耐 性 等 を解 析 した,
MRSAの 同 定=6.5%加 ブイ ヨ ソaソ ニ ッ ト培 地,
OPAブ ドウ 球 菌寒 天 培 地,コ ア グ ラ ー ゼ テ ス5で
黄 色 ブ ドウ 球 菌 を 分 離,同 定 し,Kirby-Bauer法
(Sensi・D且sk,日本 ベ ク トソー デ ッキ ン ソン)でoxa'
cillin,methcillinに対 して阻 止 円 径 がそ れ ぞ れ10
mm以 下,9mm以 下 の場 合MRSAと 判 定 した15).





FLX),fosfomycin(FOM)につ い て デ ィス ク拡 散
法(Sensi-Disk,日本 ベ ク トソー デ ッキ ン ソソ)で 判
Tablel.患 者 背 景
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Table2.治 療 と 転 帰

















































































例,腎 孟 腫 瘍1例,神 経 因 性膀 胱1例,ボ ア リ氏 手術
後1例 で あ った.尿 道 カ テー テ ルは3例 に留 置 され て
い た.3例 に38度以上 の 発 熱を 認 め た.混 合感 染 は10
例 に認 め られ 大 陽菌2例,プ ロテ ウス1例,カ ソジ ダ
1例,ク レブ シ ェ ラ2例,緑 膿 菌2例,セ ラチ ア2例
で あ った.先 行 抗生 剤 は4例 に投 与 され て お り第3世
代 セ フ ェム3例,ペ ニ シ リン系1例 であ った.
薬 剤 感受 性 をTable3に 示 す.感 受 性 はVCM
loo%,IMP/cs31%,MINo31%,AMK31%,
FOM7%で あ った.














































































































































































































が担癌患者であ り残 りの6例 も尿路の閉塞を伴うなど
全身あるいは局所感染防御能 の低下が予想 された,
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